ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,127.79
      1.26%
      US Tech 100
      17,463.60
      0.25%
      Dow Jones
      38,675.68
      1.18%
      Brent Oil
      83.575
      0.54%
      Bitcoin
      65,204.59
      1.88%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Vallon Pharmaceuticals Inc (VLON)

      7. Vallon Pharmaceuticals Inc (VLON) News

      VLON

      Vallon Pharmaceuticals (VLON)

      Vallon Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:VLON
      DateTimeSourceHeadlineSymbolCompany
      04/01/20249:13AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VLONVallon Pharmaceuticals Inc
      03/28/20244:45PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VLONVallon Pharmaceuticals Inc
      03/28/20244:42PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VLONVallon Pharmaceuticals Inc
      02/02/20244:25PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VLONVallon Pharmaceuticals Inc
      02/02/20244:23PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VLONVallon Pharmaceuticals Inc
      02/02/20244:21PMEdgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:VLONVallon Pharmaceuticals Inc
      02/02/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:VLONVallon Pharmaceuticals Inc
      01/30/20248:13AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VLONVallon Pharmaceuticals Inc
      01/30/20248:12AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VLONVallon Pharmaceuticals Inc
      01/19/20244:16PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VLONVallon Pharmaceuticals Inc
      01/19/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VLONVallon Pharmaceuticals Inc
      01/16/20248:45AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VLONVallon Pharmaceuticals Inc
      12/20/20235:12PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:VLONVallon Pharmaceuticals Inc
      12/18/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:VLONVallon Pharmaceuticals Inc
      12/15/20235:02PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VLONVallon Pharmaceuticals Inc
      12/05/20239:07AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VLONVallon Pharmaceuticals Inc
      11/27/20238:38AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VLONVallon Pharmaceuticals Inc
      11/24/20234:04PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VLONVallon Pharmaceuticals Inc
      11/15/20238:07AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VLONVallon Pharmaceuticals Inc
      11/01/20238:45AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VLONVallon Pharmaceuticals Inc
      10/13/20234:40PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:VLONVallon Pharmaceuticals Inc
      08/25/20234:42PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VLONVallon Pharmaceuticals Inc
      08/23/20239:07AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VLONVallon Pharmaceuticals Inc
      08/14/20234:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VLONVallon Pharmaceuticals Inc
      08/14/20238:08AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VLONVallon Pharmaceuticals Inc
      08/14/20238:06AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VLONVallon Pharmaceuticals Inc
      07/07/20234:03PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VLONVallon Pharmaceuticals Inc
      07/06/20234:28PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:VLONVallon Pharmaceuticals Inc
      06/08/20236:02AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:VLONVallon Pharmaceuticals Inc
      06/07/20234:19PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:VLONVallon Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:VLON